Novartis to invest $480M in China following AstraZeneca and Lilly pledges
Novartis to invest $480M in China following AstraZeneca and Lilly pledges
Novartis to invest $480M in China following AstraZeneca and Lilly pledges
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.